Tempest Therapeutics Inc. (NASDAQ: TPST) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TEMPEST THERAPEUTICS INC.

Tempest Therapeutics Inc. (NASDAQ: TPST)
Listen to this Section


$1.28
-0.0300 ( -2.29% ) 86.7K

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Market Data


Open $1.28
Previous Close $1.31
Volume 86.7K
Market Cap $19.40M
Day Range $1.23 - $1.39
52 Week Range $1.20 - $6.12
Shares Outstanding 14.81M
Change % -2.29%
Net Change ▼ -0.0300
Insider Ownership -0.15%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -2,038,328.00

Date Type Amount Purchased Purchaser
2024-08-12 Sale -400000.00 Versant Venture Capital VI, L.P.
2024-07-08 Buy 35000.00 Brady Stephen R
2024-07-03 Buy 4672.00 Whiting Samuel
2024-07-02 Buy 7500.00 Trojanowski Justin
2024-06-14 Sale -16000.00 RAAB MICHAEL
2024-06-14 Sale -16000.00 Simantov Ronit
2024-06-14 Sale -16000.00 Pellizzari Christine A
2024-06-14 Sale -16000.00 NICHOL GEOFFREY
2024-01-05 Sale -26500.00 Trojanowski Justin
2024-01-05 Sale -250000.00 Brady Stephen R

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 05, 2025
10-q Quarterly Reports 60 Nov 05, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 66 Aug 11, 2025
8-k 8K-related 17 Jun 12, 2025
8-k 8K-related 13 Jun 11, 2025
8-k 8K-related 13 Jun 06, 2025

Latest News


× Before browsing our site, please accept our cookies policy